Skip to main content
. Author manuscript; available in PMC: 2010 Nov 3.
Published in final edited form as: Bioorg Med Chem. 2010 Apr 20;18(22):7739–7745. doi: 10.1016/j.bmc.2010.04.039

Table 1.

*. NIMH Psychoactive Drug Screening Program (PDSP) data for metergoline.

Receptor Ki, IC50, Kd (nM) Receptor Ki, IC50, Kd (nM) Receptor Ki, IC50, Kd (nM)
5HT1a 10
5HT1b 28 D1 9 α1a 30/97.7**
5HT1d 0.9 D2 74 α1b 123
5HT1e 1659 D3 14 α1d 91
5HT2a 7.1 D4 4.9 α2a 31
5HT2b 2.6 α2b 41
5HT2c 9.5 H1 98.2** α2c 30
5HT3 >10,000 H2 110/104**
5HT4 1274 H4 12.7* DOR 18.9*
5HT5a 562 KOR 63.2*
5HT6 91
5HT7 18 EP3 21.7** M1 1.2**
SERT 89.7** EP4 15.2** M2 17.7**
NET 1132 M3 3.8**
M4 36.9**
*

See PDSP website for experimental details for each assay.

**

denotes primary binding assay.